RxDoctor Payments Data

Jeffrey Blake, MD

Urogynecology and Reconstructive Pelvic Surgery · Noblesville, INNPI 1477545127

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 39.4% of the total. Reporting peaked in 2021 at $4,873 and has fallen 82.6% since, to $846 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,680in general payments, 2019–2025

Across 156 payments — averaging $94.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Axonics, Inc.$3K
  • AbbVie$2K
  • Coloplast$2K
  • Stryker$672
  • Astellas Pharma US Inc$179
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$2,08114%
  • Speaking & faculty fees$2,00014%
  • Travel & lodging$5,76639%
  • Food & beverage$4,80733%
  • Gifts$270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,680 in reported general payments places this provider in the 90th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.

See all urogynecology and reconstructive pelvic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$10,042
Medicare patients
23
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol27$1,635
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst34$603
Fluconazole19$197

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Noblesville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →